During the last session, CVS Health Corp (NYSE:CVS)’s traded shares were 6.37 million, with the beta value of the company hitting 0.52. At the end of the trading day, the stock’s price was $74.58, reflecting an intraday gain of 0.92% or $0.68. The 52-week high for the CVS share is $83.25, that puts it down -11.63 from that peak though still a striking 13.64% gain since the share price plummeted to a 52-week low of $64.41. The company’s market capitalization is $93.86B, and the average intraday trading volume over the past 10 days was 10.49 million shares, and the average trade volume was 11.28 million shares over the past three months.
CVS Health Corp (NYSE:CVS) trade information
CVS Health Corp (CVS) registered a 0.92% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.92% in intraday trading to $74.58, hitting a weekly high. The stock’s 5-day price performance is -6.49%, and it has moved by 0.32% in 30 days. Based on these gigs, the overall price performance for the year is -2.19%. The short interest in CVS Health Corp (NYSE:CVS) is 18.64 million shares and it means that shorts have 2.07 day(s) to cover.
CVS Health Corp (CVS) estimates and forecasts
Statistics show that CVS Health Corp has outperformed its competitors in share price, compared to the industry in which it operates. CVS Health Corp (CVS) shares have gone up 8.12% during the last six months, with a year-to-date growth rate more than the industry average at -4.69% against -14.00. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -22.30% this quarter and then jump 0.50% in the quarter after that. In the rating firms’ projections, revenue will increase 3.60% compared to the previous financial year.
Revenue for the current quarter is expected to be $89.26 billion as predicted by 17 analyst(s). Meanwhile, a consensus of 17 analyst(s) estimates revenue growth to $92.22 billion by the end of Jun 2024. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $80.81 billion and $88.92 billion respectively. In this case, analysts expect current quarter sales to grow by 10.50% and then jump by 3.70% in the coming quarter.
While earnings are projected to return -5.14% in 2024, the next five years will return 3.69% per annum.
CVS Dividends
CVS Health Corp is due to release its next quarterly earnings on May 01. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for CVS Health Corp is 2.48, with the dividend yield indicating at 3.33 percent, continuing the trend of increasing dividends in recent years.
CVS Health Corp (NYSE:CVS)’s Major holders
CVS Health Corp insiders own 0.12% of total outstanding shares while institutional holders control 83.03%, with the float percentage being 83.13%. Vanguard Group Inc is the largest shareholder of the company, while 2,785 institutions own stock in it. As of Jun 29, 2023, the company held over 116.68 million shares (or 9.08% of all shares), a total value of $8.07 billion in shares.
The next largest institutional holding, with 93.73 million shares, is of Blackrock Inc.’s that is approximately 7.30% of outstanding shares. At the market price on Jun 29, 2023, these shares were valued at $6.48 billion.
Also, the Mutual Funds coming in first place with the largest holdings of CVS Health Corp (CVS) shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. Data provided on Jun 29, 2023 indicates that Vanguard Total Stock Market Index Fund owns about 39.97 million shares. This amounts to just over 3.11 percent of the company’s overall shares, with a $2.76 billion market value. The same data shows that the other fund manager holds slightly less at 30.52 million, or about 2.38% of the stock, which is worth about $2.11 billion.
